[go: up one dir, main page]

ES1213364U - COMPOSITION OF CÚRCUMA EXTRACT (Machine-translation by Google Translate, not legally binding) - Google Patents

COMPOSITION OF CÚRCUMA EXTRACT (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES1213364U
ES1213364U ES201830590U ES201830590U ES1213364U ES 1213364 U ES1213364 U ES 1213364U ES 201830590 U ES201830590 U ES 201830590U ES 201830590 U ES201830590 U ES 201830590U ES 1213364 U ES1213364 U ES 1213364U
Authority
ES
Spain
Prior art keywords
weight
composition
composition according
extract
curcuma longa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201830590U
Other languages
Spanish (es)
Other versions
ES1213364Y (en
Inventor
Josep Manuel LLABRÉS LAGUARDA
Óscar FERNÁNDEZ FRANCISCO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plantas Medicinales y Complementos Alimenticios SA
Original Assignee
Plantas Medicinales y Complementos Alimenticios SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plantas Medicinales y Complementos Alimenticios SA filed Critical Plantas Medicinales y Complementos Alimenticios SA
Priority to ES201830590U priority Critical patent/ES1213364Y/en
Publication of ES1213364U publication Critical patent/ES1213364U/en
Application granted granted Critical
Publication of ES1213364Y publication Critical patent/ES1213364Y/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composition comprising: - Water-soluble fraction of Curcuma longa rhizome extract and - curcuminoids complexed with β -cyclodextrin characterized in that the water-soluble fraction of the Curcuma longa rhizome extract comprises between 5 - 25% by weight of turmeric polysaccharides. (Machine-translation by Google Translate, not legally binding)

Description

55

1010

15fifteen

20twenty

2525

3030

COMPOSICIÓN DE EXTRACTO DE CÚRCUMA Campo de la invenciónCOMPOSITION OF COURT EXTRACT Field of the Invention

La presente invención se refiere a una composición a base de extracto de cúrcuma para la suplementación de alimentos.The present invention relates to a composition based on turmeric extract for food supplementation.

Estado de la técnicaState of the art

La cúrcuma es una planta herbácea perenne rizomatosa de la familia Zingiberaceae originaria del sudeste de Asia, que crece en hábitats con temperaturas cálidas (entre 20 y 30 °C) y con una humedad considerable.Turmeric is a rhizomatous perennial herbaceous plant of the Zingiberaceae family native to Southeast Asia, which grows in habitats with warm temperatures (between 20 and 30 ° C) and with considerable humidity.

La cúrcuma puede alcanzar hasta 1 metro de altura, presenta un rizoma lateral, ligeramente doblado de 1 cm a 6 cm, de color naranja; hojas grandes lanceoladas, uniformemente verdes de hasta 50 cm de largo y 7-25 cm de ancho, con un ápice agudo y caudado con la base ahusada, peciolo y vaina pubescente.Turmeric can reach up to 1 meter high, has a lateral rhizome, slightly bent from 1 cm to 6 cm, orange; large lanceolate leaves, uniformly green up to 50 cm long and 7-25 cm wide, with an acute and caudate apex with tapered base, petiole and pubescent sheath.

La cúrcuma comprende aproximadamente entre 60 - 70 % en preso de hidratos de carbono, 6 - 13 % en peso de agua, 6-8 % en preso de proteínas, 5 - 10 % en peso de grasas, 3 - 7 % en peso de minerales, 3 - 7 % en peso de aceites esenciales, 2 - 7 % en peso de fibra y 1- 6 % en peso de curcuminoides.Turmeric comprises approximately 60-70% in carbohydrate prisoner, 6 - 13% by weight of water, 6-8% in protein prisoner, 5 - 10% by weight of fat, 3 - 7% by weight of minerals, 3 - 7% by weight of essential oils, 2 - 7% by weight of fiber and 1- 6% by weight of curcuminoids.

La cúrcuma se utiliza como ingrediente alimentario, siendo una especia importante, cuya raíz seca y pulverizada o el rizoma de la planta ha sido tradicionalmente utilizado en la medicina ayurvédica india durante siglos, ya que sus propiedades son ampliamente conocidas. La cúrcuma se usa como ingrediente bioactivo y suplemento en muchos alimentos.Turmeric is used as a food ingredient, being an important spice, whose dried and powdered root or the rhizome of the plant has been traditionally used in Indian Ayurvedic medicine for centuries, since its properties are widely known. Turmeric is used as a bioactive ingredient and supplement in many foods.

Sería deseable disponer de una composición a base de extracto de cúrcuma para la suplementación de alimentos.It would be desirable to have a composition based on turmeric extract for food supplementation.

Descripción de la invenciónDescription of the invention

La presente invención proporciona una composición a base de extracto de cúrcuma para la suplementación de alimentos.The present invention provides a turmeric extract based composition for food supplementation.

Así pues, en un primer aspecto, la presente invención ser refiere a una composición (de aquí en adelante, composición de la presente invención) que comprende:Thus, in a first aspect, the present invention refers to a composition (hereinafter, composition of the present invention) comprising:

- fracción hidrosoluble del extracto de rizoma de Curcuma longa y- water soluble fraction of the rhizome extract of Curcuma longa and

- curcuminoides complejados con p-cliclodextrina- curcuminoids complexed with p-cliclodextrin

55

1010

15fifteen

20twenty

2525

3030

donde la fracción hidrosoluble del extracto de rizoma de Curcuma longa comprende entre 525 % en peso de polisacáridos de cúrcuma y al menos un 20 % en peso de flavonoides, polifenoles, saponinas y alcaloides.where the water-soluble fraction of the Curcuma longa rhizome extract comprises between 525% by weight of turmeric polysaccharides and at least 20% by weight of flavonoids, polyphenols, saponins and alkaloids.

En una realización particular, los polisacáridos de cúrcuma, son polisacáridos ukonans A, B, C and DIn a particular embodiment, the turmeric polysaccharides are ukonans polysaccharides A, B, C and D

En la presente invención por curcuminoides se refiere a curcumina, desmetoxicurcumina y bisdetoxycurcumina.In the present invention curcuminoids refers to curcumin, demethoxycurcumin and bisdetoxycurcumin.

En una realización particular, la composición de la presente invención comprende ácido ascórbico.In a particular embodiment, the composition of the present invention comprises ascorbic acid.

En otra realización, la composición de la presente invención comprende un antiaglomerante. Más en particular, el antiaglomerante es seleccionado de entre diglicéridos de ácidos grasos, sales magnésicas de ácidos grasos, óxido de silicio y sus mezclas.In another embodiment, the composition of the present invention comprises an anti-caking agent. More particularly, the anti-caking agent is selected from among diglycerides of fatty acids, magnesium salts of fatty acids, silicon oxide and mixtures thereof.

En otra realización particular, la composición de la presente invención comprende:In another particular embodiment, the composition of the present invention comprises:

- 51 - 89 % en peso de fracción hidrosoluble de extracto de rizoma de Cúrcuma longa,- 51 - 89% by weight of water-soluble fraction of Curcuma longa rhizome extract,

- 4 - 9 % en peso del complejo de curcuminoides- p-ciclodrextrina,- 4 - 9% by weight of the curcuminoid-p-cyclodrextrin complex,

- 4 - 34 % en peso de ácido ascórbico,- 4 - 34% by weight of ascorbic acid,

- 2 - 5 % en peso de antiaglomerante.- 2 - 5% by weight of anti-caking agent.

En otra realización más en particular, la composición de la presente invención, comprende:In another more particular embodiment, the composition of the present invention comprises:

- 51 - 89 % en peso de fracción hidrosoluble de extracto de rizoma de cúrcuma longa,- 51 - 89% by weight of water soluble fraction of turmeric longa rhizome extract,

- 4 - 9 % en peso del complejo de curcuminoides- p-ciclodrextrina,- 4 - 9% by weight of the curcuminoid-p-cyclodrextrin complex,

- 4 - 34 % en peso de ácido ascórbico,- 4 - 34% by weight of ascorbic acid,

- 0 - 3 % en peso de diglicéridos de ácidos grasos,- 0 - 3% by weight of fatty acid diglycerides,

- 0 - 1 % en peso de sales magnésicas de ácidos grasos,- 0 - 1% by weight of magnesium salts of fatty acids,

- 0 - 1 % en peso de óxido de silicio.- 0 - 1% by weight of silicon oxide.

En otra realización más en particular, la composición de la presente invención se encuentra en forma de polvo.In another more particular embodiment, the composition of the present invention is in powder form.

En otra realización más en particular, la composición de la presente invención se encuentra encapsulada.In another more particular embodiment, the composition of the present invention is encapsulated.

En otra realización más en particular, la composición de la presente invención se encuentra en forma de comprimidos.In another more particular embodiment, the composition of the present invention is in the form of tablets.

Descripción detallada de la invenciónDetailed description of the invention

La tabla 1 muestra tres ejemplos de la composición de la presente invención.Table 1 shows three examples of the composition of the present invention.

Composición 1 Composición 2 Composición 3  Composition 1 Composition 2 Composition 3

Ingrediente  Ingredient
cantidad (mg) % en peso cantidad (mg) % en peso cantidad (mg) % en peso  quantity (mg)% by weight quantity (mg)% by weight quantity (mg)% by weight

Extracto de rizoma de Cúrcuma longa  Curcuma longa rhizome extract
500 87 100 89 1500 51  500 87 100 89 1500 51

Complejos de curcuminoides- p -ciclodextrina  Curcuminoid complexes- p -cyclodextrin
19,5 3 5 4 270 9  19.5 3 5 4 270 9

Ácido ascórbico  Ascorbic acid
23 4 5 4 1000 34  23 4 5 4 1000 34

Diglicéridos de ácidos grasos (E-471, GRAS)  Diglycerides of fatty acids (E-471, GRAS)
20 3 0 0 100 3  20 3 0 0 100 3

Sales magnésicas de ácidos grasos (E-470b)  Magnesic salts of fatty acids (E-470b)
5 1 1 0,9 20 0,7  5 1 1 0.9 20 0.7

Óxido de silicio (E-551)  Silicon Oxide (E-551)
5 1 1 0,9 20 0,7  5 1 1 0.9 20 0.7

Todas las composiciones descritas en la tabla 1 fueron preparadas de la misma forma, 5 cambiando las cantidades de cada componente y siguiendo el siguiente procedimiento:All the compositions described in Table 1 were prepared in the same way, 5 changing the amounts of each component and following the following procedure:

En primer lugar, se pesaron cada uno de los componentes para utilizarlos en las cantidades que se describen en la tabla 1. Posteriormente, se tamizaron por un tamiz con un tamaño de luz de 600 micras y posteriormente se mezclaron hasta homogeneidad total de la fórmula. Esta mezcla, se encapsuló mediante un procedimiento estándar en el estado de la técnica. 10 En este caso en concreto se utilizaron unas cápsulas vegetales de dióxido de titanio, óxido de hierro y hidroxipropilmetil celulosa. Las diferentes etapas del proceso se validaron mediante análisis del contenido en ácido ascórbico de los diferentes productos intermedios, así como del producto final.First, each of the components were weighed for use in the amounts described in Table 1. Subsequently, they were screened by a sieve with a light size of 600 microns and subsequently mixed until total homogeneity of the formula. This mixture was encapsulated by a standard procedure in the state of the art. 10 In this particular case, vegetable capsules of titanium dioxide, iron oxide and hydroxypropylmethyl cellulose were used. The different stages of the process were validated by analyzing the ascorbic acid content of the different intermediates, as well as the final product.

Claims (9)

55 1010 15fifteen 20twenty REIVINDICACIONES 1. Composición que comprende:1. Composition comprising: - fracción hidrosoluble del extracto de rizoma de Curcuma longa y- water soluble fraction of the rhizome extract of Curcuma longa and - curcuminoides complejados con p-cliclodextrina- curcuminoids complexed with p-cliclodextrin caracterizado por que la fracción hidrosoluble del extracto de rizoma de Curcuma longa comprende entre 5-25% en peso de polisacáridos de cúrcuma.characterized in that the water-soluble fraction of the Curcuma longa rhizome extract comprises between 5-25% by weight of turmeric polysaccharides. 2. Composición según la reivindicación 1, que comprende ácido ascórbico.2. Composition according to claim 1, comprising ascorbic acid. 3. Composición según cualquiera de las reivindicaciones 1-2 que comprende un antiaglomerante.3. Composition according to any of claims 1-2 comprising an anti-caking agent. 4. Composición según la reivindicación 3, donde el antiaglomerante es seleccionado de entre diglicéridos de ácidos grasos, sales magnésicas de ácidos grasos, óxido de silicio y sus mezclas.4. Composition according to claim 3, wherein the anti-caking agent is selected from among fatty acid diglycerides, magnesium salts of fatty acids, silicon oxide and mixtures thereof. 5. Composición según cualquiera de las reivindicaciones anteriores, que comprende:5. Composition according to any of the preceding claims, comprising: - 51 - 89 % en peso de fracción hidrosoluble de extracto de rizoma de Curcuma longa,- 51 - 89% by weight of water soluble fraction of Curcuma longa rhizome extract, - 4 - 9 % en peso del complejo de curcuminoides- p-ciclodrextrina,- 4 - 9% by weight of the curcuminoid-p-cyclodrextrin complex, - 4 - 34 % en peso de ácido ascórbico,- 4 - 34% by weight of ascorbic acid, - 2 - 5 % en peso de antiaglomerante.- 2 - 5% by weight of anti-caking agent. 6. Composición según cualquiera de las reivindicaciones anteriores, que comprende6. Composition according to any of the preceding claims, comprising - 51 - 89 % en peso de extracto de rizoma de Curcuma longa,- 51 - 89% by weight of Curcuma longa rhizome extract, - 4 - 9 % en peso del complejo de curcuminoides- p-ciclodrextrina,- 4 - 9% by weight of the curcuminoid-p-cyclodrextrin complex, - 4 - 34 % en peso de ácido ascórbico,- 4 - 34% by weight of ascorbic acid, - 0 - 3 % en peso de diglicéridos de ácidos grasos,- 0 - 3% by weight of fatty acid diglycerides, - 0 - 1 % en peso de sales magnésicas de ácidos grasos,- 0 - 1% by weight of magnesium salts of fatty acids, - 0 - 1 % en peso de óxido de silicio.- 0 - 1% by weight of silicon oxide. 7. Composición según cualquiera de las reivindicaciones anteriores, que está en forma de polvo.7. Composition according to any of the preceding claims, which is in powder form. 8. Composición según cualquiera de las reivindicaciones anteriores, que se encuentra encapsulada.8. Composition according to any of the preceding claims, which is encapsulated. 9. Composición según cualquiera de las reivindicaciones 1-7, que se encuentra en forma de comprimido.9. Composition according to any of claims 1-7, which is in the form of a tablet.
ES201830590U 2018-04-24 2018-04-24 CURCUMA EXTRACT COMPOSITION Active ES1213364Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201830590U ES1213364Y (en) 2018-04-24 2018-04-24 CURCUMA EXTRACT COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201830590U ES1213364Y (en) 2018-04-24 2018-04-24 CURCUMA EXTRACT COMPOSITION

Publications (2)

Publication Number Publication Date
ES1213364U true ES1213364U (en) 2018-05-30
ES1213364Y ES1213364Y (en) 2018-09-11

Family

ID=62201118

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201830590U Active ES1213364Y (en) 2018-04-24 2018-04-24 CURCUMA EXTRACT COMPOSITION

Country Status (1)

Country Link
ES (1) ES1213364Y (en)

Also Published As

Publication number Publication date
ES1213364Y (en) 2018-09-11

Similar Documents

Publication Publication Date Title
Thirupathi et al. A review of medicinal plants of the genus Cordia: Their chemistry and pharmacological uses
Irondi et al. Effect of drying methods on the phytochemicals composition and antioxidant activities of Carica papaya seed
Sharifi-Rad et al. Genus Viburnum: Therapeutic Potentialities and Agro‐Food‐Pharma Applications
JP2022512960A (en) Method of preparing herbal extract and composition of herbal extract
JP2017105728A (en) Hyperglycemic inhibitor and intestinal function-controlling medicine
US11696900B2 (en) Tri-molecular complex of natural compounds
Ansari et al. A review on ginger (Zingiber officinale Rosc) with unani perspective and modern pharmacology
Manimekalai et al. Antioxidant and anticancer potential of mangosteen fruit, Garcinia mangostana against hepatocellular carcinoma (HePG-2) cell line
Thorat Review on Celosia argentea L. plant
Lahlou et al. Screening of antioxidant activity and the total polyphenolic contents of six medicinal Moroccan's plants extracts
Pattanayak Anti-COVID-19 biomedicines-a layout proposal for production, storage and transportation
KR102245269B1 (en) Multilayer Coating Soft Capsule
CN105451753A (en) Compositions for enhancing semen quality in male subjects
ES1213364U (en) COMPOSITION OF CÚRCUMA EXTRACT (Machine-translation by Google Translate, not legally binding)
Le et al. Natural plant colorants widely used in Vietnam traditional food culture
Gautam et al. Exploration of preliminary phytochemical studies of leaves of Murraya paniculata (L.).
Sikarwar et al. Antioxidant activity of Artocarpus altilis (Parkinson) Fosberg leaves
Vijayalakshmi et al. Pharmacognostical and phytochemical screening of the peels of Citrus maxima
Al Naqbi et al. Exploring the antioxidant potential of medicinal plants in the United Arab Emirates (UAE): Emphasizing their significance in novel drug development
Buera et al. Ibero‐American Network as a Collaborative Strategy to Provide Tools for the Development of Phytopharmaceuticals and Nutraceuticals
Sageer et al. PLANT INGREDIENT SCREENING AS POTENTIAL EXCIPIENTS FOR PHARMACEUTICAL DOSAGE FORMS.
Bhatt et al. Pharmacognostic and preliminary phytochemical studies on the leaf of Beta vulgaris Linn.(Chenopodiaceae)
SALANTA et al. The potential of medicinal plants in developing functional foods
JP7569563B2 (en) Blood sugar level rise suppressant and intestinal regulator
Suwan et al. Development of Babbler’s Bill leaf carragenan jellies

Legal Events

Date Code Title Description
FG1K Utility model granted

Effective date: 20180905

Ref document number: 1213364

Country of ref document: ES

Kind code of ref document: Y

Effective date: 20180905